Header Logo

Connection

JASVINDER SINGH to Gout

Back to Details
This is a "connection" page, showing publications JASVINDER SINGH has written about Gout.
JASVINDER SINGH
Connection Strength
41.238
Gout
  1. Clustering Patients With Gout Based on Comorbidities and Biomarkers: A Cross-Sectional Study. J Rheumatol. 2023 06; 50(6):817-826.
    View in: PubMed
    Score: 0.654
  2. Epidemiology and Outcomes of Alcohol Use Hospitalizations in People With Gout, Rheumatoid Arthritis, Fibromyalgia, Osteoarthritis, or Low Back Pain: A National US Study. J Clin Rheumatol. 2022 03 01; 28(2):e375-e380.
    View in: PubMed
    Score: 0.619
  3. SToRytelliing to Improve Disease outcomes in Gout (STRIDE-GO) in African American veterans with gout: a trial study protocol. Trials. 2021 Dec 04; 22(1):879.
    View in: PubMed
    Score: 0.609
  4. SToRytelling to Improve Disease outcomes in Gout (STRIDE-GO): a multicenter, randomized controlled trial in African American veterans with gout. BMC Med. 2021 11 09; 19(1):265.
    View in: PubMed
    Score: 0.606
  5. Dual-energy computed tomography vs ultrasound, alone or combined, for the diagnosis of gout: a prospective study of accuracy. Rheumatology (Oxford). 2021 10 02; 60(10):4861-4867.
    View in: PubMed
    Score: 0.602
  6. Comment on: Dual-energy computed tomography versus ultrasound, alone or combined, for the diagnosis of gout: a prospective study of accuracy: reply. Rheumatology (Oxford). 2021 10 02; 60(10):e372-e374.
    View in: PubMed
    Score: 0.602
  7. Cardiovascular safety of febuxostat. Lancet. 2021 09 11; 398(10304):955.
    View in: PubMed
    Score: 0.600
  8. Serious Infections in Patients With Gout in the US: A?National Study of Incidence, Time Trends, and Outcomes. Arthritis Care Res (Hoboken). 2021 06; 73(6):898-908.
    View in: PubMed
    Score: 0.588
  9. How do dietary interventions affect serum urate and gout? Nat Rev Rheumatol. 2021 04; 17(4):191-192.
    View in: PubMed
    Score: 0.581
  10. The changing epidemiology of inpatient gout and associated mortality: a 17-year national study. Rheumatology (Oxford). 2021 01 05; 60(1):462-465.
    View in: PubMed
    Score: 0.572
  11. Time Trends in Opioid Use Disorder Hospitalizations in Gout, Rheumatoid Arthritis, Fibromyalgia, Osteoarthritis, and Low Back Pain. J Rheumatol. 2021 05; 48(5):775-784.
    View in: PubMed
    Score: 0.562
  12. Shared decision-making in gout treatment: a national study of rheumatology provider opinion and practice. Clin Rheumatol. 2021 Feb; 40(2):693-700.
    View in: PubMed
    Score: 0.561
  13. Patient-Centered Outcomes and Key Study Procedure Finalization in the Pilot Feasibility Gout Randomized Trial: Comparative Feasibility Study in GOUt, CHerry Extract Versus Diet Modification (Mini-GOUCH). J Clin Rheumatol. 2020 Aug; 26(5):181-191.
    View in: PubMed
    Score: 0.555
  14. Response to: 'Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the artcile by Singh and Clevland' by Quills et al. Ann Rheum Dis. 2022 07; 81(7):e125.
    View in: PubMed
    Score: 0.552
  15. Response to: 'Correspondence to "Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data' by Ma et al. Ann Rheum Dis. 2022 06; 81(6):e108.
    View in: PubMed
    Score: 0.551
  16. Response to: 'Confunding by indication and ethnicity difference? Comment on 'Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data'' by Hsu et al. Ann Rheum Dis. 2022 07; 81(7):e123.
    View in: PubMed
    Score: 0.551
  17. Patient Perceptions of Gout Management Goals: A Cross-sectional Internet Survey. J Clin Rheumatol. 2020 Jun; 26(4):129-133.
    View in: PubMed
    Score: 0.549
  18. A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout. J Clin Rheumatol. 2020 Jun; 26(4):147-156.
    View in: PubMed
    Score: 0.549
  19. Gout epidemiology and comorbidities. Semin Arthritis Rheum. 2020 06; 50(3S):S11-S16.
    View in: PubMed
    Score: 0.549
  20. Are the days of missed or delayed diagnosis of gout over? Nat Rev Rheumatol. 2019 10; 15(10):578-580.
    View in: PubMed
    Score: 0.524
  21. Comparative effectiveness of allopurinol and febuxostat for the risk of atrial fibrillation in the elderly: a propensity-matched analysis of Medicare claims data. Eur Heart J. 2019 09 21; 40(36):3046-3054.
    View in: PubMed
    Score: 0.523
  22. Factors Influencing the Effectiveness of Allopurinol in Achieving and Sustaining Target Serum Urate in a US Veterans Affairs Gout Cohort. J Rheumatol. 2020 03; 47(3):449-460.
    View in: PubMed
    Score: 0.519
  23. Cardiovascular Disease in Gout and the?Protective Effect of Treatments Including Urate-Lowering Therapy. Drugs. 2019 Apr; 79(5):531-541.
    View in: PubMed
    Score: 0.506
  24. Gout and chronic pain in older adults: a Medicare claims study. Clin Rheumatol. 2019 Jul; 38(7):1953-1960.
    View in: PubMed
    Score: 0.506
  25. Gout is associated with a higher risk of chronic renal disease in older adults: a retrospective cohort study of U.S. Medicare population. BMC Nephrol. 2019 03 15; 20(1):93.
    View in: PubMed
    Score: 0.504
  26. The risk of Sjogren's syndrome in the older adults with gout: A medicare claims study. Joint Bone Spine. 2019 Oct; 86(5):615-619.
    View in: PubMed
    Score: 0.501
  27. Self-reported sleep quality and sleep disorders in people with physician-diagnosed gout: an Internet cross-sectional survey. Arthritis Res Ther. 2019 01 25; 21(1):36.
    View in: PubMed
    Score: 0.500
  28. Gout and healthcare utilization and complications after hip arthroplasty: a cohort study using the US National Inpatient Sample (NIS). Clin Rheumatol. 2019 Apr; 38(4):1213-1216.
    View in: PubMed
    Score: 0.499
  29. Gout and the risk of Parkinson's disease in older adults: a study of U.S. Medicare data. BMC Neurol. 2019 Jan 05; 19(1):4.
    View in: PubMed
    Score: 0.498
  30. Gout and dementia in the elderly: a cohort study of Medicare claims. BMC Geriatr. 2018 11 14; 18(1):281.
    View in: PubMed
    Score: 0.493
  31. Any sleep is a dream far away: a nominal group study assessing how gout affects sleep. Rheumatology (Oxford). 2018 11 01; 57(11):1925-1932.
    View in: PubMed
    Score: 0.492
  32. Gout and the risk of incident depression in older adults. Psychiatry Res. 2018 12; 270:842-844.
    View in: PubMed
    Score: 0.491
  33. Gout and the Risk of Incident Obstructive Sleep Apnea in Adults 65 Years or Older: An Observational Study. J Clin Sleep Med. 2018 09 15; 14(9):1521-1527.
    View in: PubMed
    Score: 0.487
  34. Gout and hearing impairment in the elderly: a retrospective cohort study using the US Medicare claims data. BMJ Open. 2018 08 20; 8(8):e022854.
    View in: PubMed
    Score: 0.485
  35. Goals of gout treatment: a patient perspective. Clin Rheumatol. 2018 Sep; 37(9):2557-2566.
    View in: PubMed
    Score: 0.483
  36. Gout and Hypothyroidism in the Elderly: an Observational Cohort Study Using U.S. Medicare Claims Data. J Gen Intern Med. 2018 08; 33(8):1229-1231.
    View in: PubMed
    Score: 0.483
  37. Gout and the risk of age-related macular degeneration in the elderly. PLoS One. 2018; 13(7):e0199562.
    View in: PubMed
    Score: 0.481
  38. Association of Gout With Uveitis in Older Individuals. JAMA Ophthalmol. 2018 07 01; 136(7):835-837.
    View in: PubMed
    Score: 0.480
  39. The association of gout with incident giant cell arteritis in older adults. Joint Bone Spine. 2019 03; 86(2):219-224.
    View in: PubMed
    Score: 0.478
  40. Gout and the risk of myocardial infarction in older adults: a study of Medicare recipients. Arthritis Res Ther. 2018 06 01; 20(1):109.
    View in: PubMed
    Score: 0.478
  41. Response to: 'Use of urate-lowering therapies is not associated with an increase in the risk of incident dementia in older adults' by Lee and Song. Ann Rheum Dis. 2018 10; 77(10):e74.
    View in: PubMed
    Score: 0.460
  42. Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study. Arthritis Res Ther. 2017 Oct 17; 19(1):228.
    View in: PubMed
    Score: 0.457
  43. Response to: 'A response to Singh. "Lesinurad combination therapy with allopurinol in gout: do CLEAR studies make the treatment of gout clearer?"' by Valiyil and Schechter. Ann Rheum Dis. 2018 07; 77(7):e42.
    View in: PubMed
    Score: 0.456
  44. Gout Self-Management in African American Veterans: A Qualitative Exploration of Challenges and Solutions From Patients' Perspectives. Arthritis Care Res (Hoboken). 2017 11; 69(11):1724-1732.
    View in: PubMed
    Score: 0.456
  45. Role of serum urate in neurocognitive function and dementia: new evidence contradicts old thinking. Ann Rheum Dis. 2018 03; 77(3):317-318.
    View in: PubMed
    Score: 0.455
  46. Gout and comorbidity: a nominal group study of people with gout. Arthritis Res Ther. 2017 09 15; 19(1):204.
    View in: PubMed
    Score: 0.455
  47. Management of Gout. Ann Intern Med. 2017 06 06; 166(11):855.
    View in: PubMed
    Score: 0.446
  48. Health care utilization in patients with gout: a prospective multicenter cohort study. BMC Musculoskelet Disord. 2017 05 31; 18(1):233.
    View in: PubMed
    Score: 0.446
  49. EULAR gout treatment guidelines by Richette et al.: uric acid and neurocognition. Ann Rheum Dis. 2018 04; 77(4):e20.
    View in: PubMed
    Score: 0.440
  50. Allopurinol and the risk of ventricular arrhythmias in the elderly: a study using US Medicare data. BMC Med. 2017 03 22; 15(1):59.
    View in: PubMed
    Score: 0.440
  51. Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes. BMC Cardiovasc Disord. 2017 03 14; 17(1):76.
    View in: PubMed
    Score: 0.439
  52. Lesinurad combination therapy with allopurinol in gout: do CLEAR studies make the treatment of gout clearer? Ann Rheum Dis. 2017 05; 76(5):779-781.
    View in: PubMed
    Score: 0.433
  53. Chasing crystals out of the body: will treat to serum urate target for gout help us get there? Ann Rheum Dis. 2017 04; 76(4):629-631.
    View in: PubMed
    Score: 0.433
  54. Gout: will the "King of Diseases" be the first rheumatic disease to be cured? BMC Med. 2016 Nov 11; 14(1):180.
    View in: PubMed
    Score: 0.429
  55. Racial differences in health-related quality of life and functional ability in patients with gout. Rheumatology (Oxford). 2017 01; 56(1):103-112.
    View in: PubMed
    Score: 0.427
  56. Are allopurinol dose and duration of use nephroprotective in the elderly? A Medicare claims study of allopurinol use and incident renal failure. Ann Rheum Dis. 2017 Jan; 76(1):133-139.
    View in: PubMed
    Score: 0.417
  57. Time Trends, Predictors, and Outcome of Emergency Department Use for Gout: A Nationwide US Study. J Rheumatol. 2016 08; 43(8):1581-8.
    View in: PubMed
    Score: 0.413
  58. Gout-related inpatient utilization: a study of predictors of outcomes and time trends. Arthritis Res Ther. 2016 Mar 02; 18:57.
    View in: PubMed
    Score: 0.409
  59. A cross-sectional internet-based patient survey of the management strategies for gout. BMC Complement Altern Med. 2016 Mar 01; 16:90.
    View in: PubMed
    Score: 0.409
  60. A Real-World Study of Switching From Allopurinol to Febuxostat in a Health Plan Database. J Clin Rheumatol. 2015 Dec; 21(8):411-8.
    View in: PubMed
    Score: 0.402
  61. Serum urate gene associations with incident gout, measured in the Framingham Heart Study, are modified by renal disease and not by body mass index. Rheumatol Int. 2016 Feb; 36(2):263-70.
    View in: PubMed
    Score: 0.397
  62. An internet survey of common treatments used by patients with gout including cherry extract and juice and other dietary supplements. J Clin Rheumatol. 2015 Jun; 21(4):225-6.
    View in: PubMed
    Score: 0.388
  63. Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort. Arthritis Res Ther. 2015 May 12; 17:120.
    View in: PubMed
    Score: 0.386
  64. Is the double contour sign specific for gout? Or only for crystal arthritis? J Rheumatol. 2015 Mar; 42(3):353-4.
    View in: PubMed
    Score: 0.381
  65. When gout goes to the heart: does gout equal a cardiovascular disease risk factor? Ann Rheum Dis. 2015 Apr; 74(4):631-4.
    View in: PubMed
    Score: 0.378
  66. Challenges faced by patients in gout treatment: a qualitative study. J Clin Rheumatol. 2014 Apr; 20(3):172-4.
    View in: PubMed
    Score: 0.358
  67. Research priorities in gout: the patient perspective. J Rheumatol. 2014 Mar; 41(3):615-6.
    View in: PubMed
    Score: 0.356
  68. Application of the OMERACT filter to measures of core outcome domains in recent clinical studies of acute gout. J Rheumatol. 2014 Mar; 41(3):574-80.
    View in: PubMed
    Score: 0.353
  69. OMERACT endorsement of measures of outcome for studies of acute gout. J Rheumatol. 2014 Mar; 41(3):569-73.
    View in: PubMed
    Score: 0.351
  70. Racial and gender disparities among patients with gout. Curr Rheumatol Rep. 2013 Feb; 15(2):307.
    View in: PubMed
    Score: 0.330
  71. Emerging therapies for gout. Expert Opin Emerg Drugs. 2012 Dec; 17(4):511-8.
    View in: PubMed
    Score: 0.325
  72. Developing a provisional definition of flare in patients with established gout. Arthritis Rheum. 2012 May; 64(5):1508-17.
    View in: PubMed
    Score: 0.313
  73. Can racial disparities in optimal gout treatment be reduced? Evidence from a randomized trial. BMC Med. 2012 Feb 09; 10:15.
    View in: PubMed
    Score: 0.308
  74. Validation of pain and patient global scales in chronic gout: data from two randomised controlled trials. Ann Rheum Dis. 2011 Jul; 70(7):1277-81.
    View in: PubMed
    Score: 0.296
  75. Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol. 2011 Jul; 38(7):1452-7.
    View in: PubMed
    Score: 0.296
  76. Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol. 2011 Mar; 23(2):192-202.
    View in: PubMed
    Score: 0.289
  77. Advances in gout: some answers, more questions. Arthritis Res Ther. 2010; 12(5):136.
    View in: PubMed
    Score: 0.280
  78. Health care utilization in patients with gout. Semin Arthritis Rheum. 2011 Jun; 40(6):501-11.
    View in: PubMed
    Score: 0.280
  79. A national survey of Veterans Affairs rheumatologists for relevance of quality of care indicators for gout management. Arthritis Care Res (Hoboken). 2010 Sep; 62(9):1306-11.
    View in: PubMed
    Score: 0.279
  80. Pegloticase for chronic gout. Cochrane Database Syst Rev. 2010 Mar 17; (3):CD008335.
    View in: PubMed
    Score: 0.270
  81. Quality of life and quality of care for patients with gout. Curr Rheumatol Rep. 2009 Apr; 11(2):154-60.
    View in: PubMed
    Score: 0.253
  82. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis. 2008 Sep; 67(9):1310-6.
    View in: PubMed
    Score: 0.232
  83. Weight Loss for Patients With Gout and Concomitant Obesity: A Proof-of-Concept Randomized Trial. Arthritis Rheumatol. 2024 May; 76(5):806-812.
    View in: PubMed
    Score: 0.178
  84. Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set. Semin Arthritis Rheum. 2023 06; 60:152191.
    View in: PubMed
    Score: 0.166
  85. Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group. Semin Arthritis Rheum. 2021 12; 51(6):1378-1385.
    View in: PubMed
    Score: 0.152
  86. Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) common language definition of gout. RMD Open. 2021 04; 7(2).
    View in: PubMed
    Score: 0.145
  87. Genetic correlations between traits associated with hyperuricemia, gout, and comorbidities. Eur J Hum Genet. 2021 09; 29(9):1438-1445.
    View in: PubMed
    Score: 0.144
  88. Which factors predict discordance between a patient and physician on a gout flare? Rheumatology (Oxford). 2021 02 01; 60(2):773-779.
    View in: PubMed
    Score: 0.144
  89. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Rheumatol. 2020 06; 72(6):879-895.
    View in: PubMed
    Score: 0.137
  90. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res (Hoboken). 2020 06; 72(6):744-760.
    View in: PubMed
    Score: 0.137
  91. Flare Rate Thresholds for Patient Assessment of Disease Activity States in Gout. J Rheumatol. 2021 02; 48(2):293-298.
    View in: PubMed
    Score: 0.136
  92. Gout is associated with an increased risk for incident heart failure among older adults: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort study. Arthritis Res Ther. 2020 04 16; 22(1):86.
    View in: PubMed
    Score: 0.136
  93. Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities. Arthritis Res Ther. 2018 05 03; 20(1):90.
    View in: PubMed
    Score: 0.119
  94. Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis. Semin Arthritis Rheum. 2018 10; 48(2):293-301.
    View in: PubMed
    Score: 0.117
  95. Brief Report: Validation of a Definition of Flare in Patients With Established Gout. Arthritis Rheumatol. 2018 03; 70(3):462-467.
    View in: PubMed
    Score: 0.117
  96. Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements. J Rheumatol. 2018 03; 45(3):419-424.
    View in: PubMed
    Score: 0.116
  97. Medication adherence among patients with gout: A systematic review and meta-analysis. Semin Arthritis Rheum. 2018 04; 47(5):689-702.
    View in: PubMed
    Score: 0.114
  98. Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies. Ann Rheum Dis. 2017 Nov; 76(11):1870-1882.
    View in: PubMed
    Score: 0.113
  99. Comparative effectiveness of allopurinol versus febuxostat for preventing incident renal disease in older adults: an analysis of Medicare claims data. Ann Rheum Dis. 2017 Oct; 76(10):1669-1678.
    View in: PubMed
    Score: 0.111
  100. Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990-2013: findings from the Global Burden of Disease Study 2013. Ann Rheum Dis. 2017 Aug; 76(8):1365-1373.
    View in: PubMed
    Score: 0.109
  101. Using serum urate as a validated surrogate end point for flares in patients with gout: protocol for a systematic review and meta-regression analysis. BMJ Open. 2016 09 20; 6(9):e012026.
    View in: PubMed
    Score: 0.106
  102. Renal dosing of allopurinol results in suboptimal gout care. Ann Rheum Dis. 2017 01; 76(1):e1.
    View in: PubMed
    Score: 0.106
  103. Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises. Arthritis Care Res (Hoboken). 2016 05; 68(5):667-72.
    View in: PubMed
    Score: 0.103
  104. Performance of Gout Impact Scale in a longitudinal observational study of patients with gout. Rheumatology (Oxford). 2016 06; 55(6):982-90.
    View in: PubMed
    Score: 0.102
  105. Investigational drugs for hyperuricemia. Expert Opin Investig Drugs. 2015; 24(8):1013-30.
    View in: PubMed
    Score: 0.097
  106. Imaging as an Outcome Measure in Gout Studies: Report from the OMERACT Gout Working Group. J Rheumatol. 2015 Dec; 42(12):2460-4.
    View in: PubMed
    Score: 0.095
  107. Comorbidities in patients with crystal diseases and hyperuricemia. Rheum Dis Clin North Am. 2014 May; 40(2):251-78.
    View in: PubMed
    Score: 0.089
  108. Outcome measures in acute gout: a systematic literature review. J Rheumatol. 2014 Mar; 41(3):558-68.
    View in: PubMed
    Score: 0.088
  109. Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials. J Rheumatol. 2012 Jul; 39(7):1450-7.
    View in: PubMed
    Score: 0.079
  110. Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities. J Rheumatol. 2011 Jul; 38(7):1458-61.
    View in: PubMed
    Score: 0.074
  111. Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology? J Rheumatol. 2011 Jul; 38(7):1462-6.
    View in: PubMed
    Score: 0.074
  112. Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trials. J Rheumatol. 2011 Jul; 38(7):1467-70.
    View in: PubMed
    Score: 0.074
  113. Minimally important differences of the gout impact scale in a randomized controlled trial. Rheumatology (Oxford). 2011 Jul; 50(7):1331-6.
    View in: PubMed
    Score: 0.072
  114. Gout in the Hmong in the United States. J Clin Rheumatol. 2010 Sep; 16(6):262-6.
    View in: PubMed
    Score: 0.070
  115. Outcome domains for studies of acute and chronic gout. J Rheumatol. 2009 Oct; 36(10):2342-5.
    View in: PubMed
    Score: 0.065
  116. Progress in measurement instruments for acute and chronic gout studies. J Rheumatol. 2009 Oct; 36(10):2346-55.
    View in: PubMed
    Score: 0.065
  117. Toward a valid definition of gout flare: results of consensus exercises using Delphi methodology and cognitive mapping. Arthritis Rheum. 2009 Apr 15; 61(4):535-43.
    View in: PubMed
    Score: 0.063
  118. Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford). 2009 May; 48(5):582-6.
    View in: PubMed
    Score: 0.063
  119. Evaluation of an instrument assessing influence of Gout on health-related quality of life. J Rheumatol. 2008 Dec; 35(12):2406-14.
    View in: PubMed
    Score: 0.061
  120. A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout. Ann Rheum Dis. 2008 Jun; 67(6):888-91.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.